Table 1

Univariate and multivariate survival analysis in GC NAC cohort

CharacteristicsNumberUnivariateMultivariate
ClassTotalEvent (OS)HR (95% CI)P valueHR (95% CI)P value
Age1.006 (0.991 to 1.020)0.450
HistologyAdenocarcinoma28316111
Signet-ring cell carcinoma (SRCC)19151.772 (1.043 to 3.009)0.0341.993 (0.968 to 4.105)0.061
Differentiation
Poor1359111
Well/moderate144740.632 (0.465 to 0.859)0.0030.636 (0.439 to 0.922)0.017
Tumor diameter
<5 cm151721
≥5 cm137971.870 (1.378 to 2.538)<0.001
Vascular invasion
Negative174801
Positive123932.605 (1.926 to 3.523)<0.001
NAC response
Responders28101
Non-responders2761672.116 (1.118 to 4.007)0.021
pTNM
I23111
II95307.711 (1.051 to 56.543)0.0453.627 (0.488 to 26.968)0.208
III1279930.607 (4.263 to 219.727)0.00112.691 (1.760 to 91.496)0.012
IV433947.637 (6.530 to 347.492)<0.00117.340 (2.346 to 128.150)0.005
CD30.982 (0.965 to 0.999)0.043
CD80.972 (0.953 to 0.991)0.0040.967 (0.946 to 0.989)0.004
CD40.984 (0.957 to 1.012)0.255
FOXP31.004 (0.906 to 1.113)0.944
Granzyme B0.943 (0.860 to 1.035)0.220
CD201.004 (0.982 to 1.027)0.725
CD680.997 (0.963 to 1.032)0.873
CD571.009 (0.987 to 1.032)0.439
  • GC, gastric cancer; NAC, neoadjuvant chemotherapy.